DUVOID 25 MG — DIN 01947931
BETHANECHOL CHLORIDE : 25 MG · ENDO OPERATIONS LTD. · TABLET · wholesale supply in Canada
Health Canada status: MARKETED
What is DUVOID?
DUVOID 25 MG contains BETHANECHOL CHLORIDE : 25 MG. It is listed in the Health Canada Drug Product Database under DIN 01947931, held by ENDO OPERATIONS LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 04-Dec-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is DUVOID used for?
The treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Bethanechol cost around the world?
Bethanechol is listed on 2 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Austria publishes a KVP (Kassenverkaufspreis); Luxembourg publishes a reimbursement. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Austria | KVP (Kassenverkaufspreis) | 2 | 2 | EUR███.██ |
| Luxembourg | reimbursement | 1 | 1 | EUR███.██ |
3 pack listings across 3 brand entries and 2 price bases, refreshed 05 Sep 2026. Ranges span every Bethanechol pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Bethanechol in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
5 holders have a Canadian DIN containing Bethanechol, across 14 DINs, of which 2 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| ENDO OPERATIONS LTD. | 3 | 2 | DUVOID | Sourceable in Canada |
| MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | 3 | 0 | URECHOLINE INJ 5MG/ML, URECHOLINE TAB 10MG, URECHOLINE TAB 25MG | No marketed DIN |
| PHARMASCIENCE INC | 3 | 0 | PMS-BETHANECHOL CHLORIDE TAB 10MG, PMS-BETHANECHOL CHLORIDE TAB 25MG, PMS-BETHANECHOL CHLORIDE TAB 50MG | No marketed DIN |
| PHARMEL INC | 3 | 0 | PHL-BETHANECHOL CHLORIDE | No marketed DIN |
| GLENWOOD LABORATORIES CANADA LTD. | 2 | 0 | MYOTONACHOL TABLETS 10MG, MYOTONACHOL TABLETS 25MG | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 25 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | 10 mg: Each pale orange, flat, beveled, round tablet, with “10” debossed on one side and debossed with a shield on the other, contains: bethanechol chloride 10 mg. Bottles of 100. 25 mg: Each white, flat, beveled, round tablet, with “25” debossed on one side and debossed with a shield on the other, contains: bethanechol chloride 25 mg. Bottles of 100. 50 mg: Each tan, flat, beveled, round tablet, with “50” debossed on one side and debossed with a shield on the other, contains: bethanechol chloride 50 mg. Bottles of 100. |
| Storage | Store below 40°C. Keep container tightly closed. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Bethanechol |
|---|---|
| ATC code | N07AB02 |
| AHFS class | 12:04.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 01947931 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1947931 |
| Brand name | DUVOID |
| Generic / active ingredient | BETHANECHOL CHLORIDE : 25 MG |
| Market authorization holder | ENDO OPERATIONS LTD. |
| Health Canada schedule | Prescription |
| ATC code | N07AB02 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N07AB |
| Current status | MARKETED |
| Status date | 04-Dec-2025 |
| Original market date | 1992-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Dosage must be individualized, depending on the type and severity of the condition to be treated. It is preferable to give the drug when the stomach is empty. If taken soon after eating, nausea and vomiting may occur. The usual adult oral dosage is 10 to 50 mg, 3 to 4 times a day. The minimum effective dose is determined by giving 5 to 10 mg initially and repeating the same amount at hourly intervals until a satisfactory response occurs or a maximum of 50 mg has been given. The effects of the drug appear within 60 to 90 minutes and persist for up to 6 hours. Individual doses should therefore, be spaced at least 6 hours apart.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hyperthyroidism, pregnancy, lactation, peptic ulcer, latent or active bronchial asthma, pronounced bradycardia or hypotension, vasomotor instability, coronary artery disease, epilepsy, parkinsonism. Should not be employed when the strength or integrity of the gastrointestinal or bladder wall is in question, or in the presence of mechanical obstruction; when increased muscular activity of the gastrointestinal tract or urinary bladder might prove harmful, as following recent urinary bladder surgery, gastrointestinal resection and anastomosis, or when there is possible gastrointestinal obstruction; in bladder neck obstruction, spastic gastrointestinal disturbances, acute inflammatory lesions of the gastrointestinal tract, or peritonitis; or in marked vagotonia.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
2 of 14 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| DUVOID | 10 MG | TABLET | ENDO OPERATIONS LTD. | MARKETED | 01947958 |
| DUVOID | 50 MG | TABLET | ENDO OPERATIONS LTD. | DORMANT | 01947923 |
| MYOTONACHOL TABLETS 10MG | 10 MG | TABLET | GLENWOOD LABORATORIES CANADA LTD. | CANCELLED POST MARKET | 01985671 |
| MYOTONACHOL TABLETS 25MG | 25 MG | TABLET | GLENWOOD LABORATORIES CANADA LTD. | CANCELLED POST MARKET | 01985558 |
| PHL-BETHANECHOL CHLORIDE | 50 MG | TABLET | PHARMEL INC | CANCELLED POST MARKET | 02237049 |
| PHL-BETHANECHOL CHLORIDE | 10 MG | TABLET | PHARMEL INC | CANCELLED POST MARKET | 02237047 |
| PHL-BETHANECHOL CHLORIDE | 25 MG | TABLET | PHARMEL INC | CANCELLED POST MARKET | 02237048 |
| PMS-BETHANECHOL CHLORIDE TAB 10MG | 10 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | 00759171 |
| PMS-BETHANECHOL CHLORIDE TAB 25MG | 25 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | 00739162 |
| PMS-BETHANECHOL CHLORIDE TAB 50MG | 50 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | 00759198 |
2 · Same class — other molecules in ATC N07AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Bethanechol | DUVOID · MYOTONACHOL TABLETS 10MG · MYOTONACHOL TABLETS 25MG · PHL-BETHANECHOL CHLORIDE · +6 more | 14 | 2 | Yes |
| Carbachol | CARBACHOL · CARBACHOL INJECTION LIQ SC 0.25MG/ML · CARBACHOL TAB 2MG | 3 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N07A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N07AA | Neostigmine · Pyridostigmine | 31 | 10 |
| N07AX | Pilocarpine | 5 | 3 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is DUVOID called?
Also recorded in Canada as: bethanechol chloride 10 MG Oral Tablet (US), bethanechol chloride 25 MG Oral Tablet (US), bethanechol chloride 5 MG Oral Tablet (US), bethanechol chloride 50 MG Oral Tablet (US), BETHANECHOL CHLORIDE (US), Urecholine (US), Bethanechol Chloride (UK), Bethanechol Chloride (JP), Urotone (IN).
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.